Search results
Author(s):
Kristian Wachtell
Added:
3 years ago
Left ventricular (LV) hypertrophy is a form of pre-clinical cardiac disease that may be induced by either pressure or volume myocardial overload, as well as genetic factors and a variety of other stimuli. Pressure overload, as exemplified by aortic stenosis, and volume overload, as exemplified by regurgitant aortic or mitral valve disease or chronic anaemia, initiates growth of cardiac myocytes…
View more
Author(s):
Isla S Mackenzie
,
Thomas M MacDonald
Added:
3 years ago
Hypertension becomes more common with increasing age. As we gradually move towards having a higher proportion of elderly people in the population, greater numbers of octogenarians are being treated for hypertension. In this article we describe the main features of hypertension in the elderly and describe some of the particular issues that affect elderly patients. We also discuss the results of…
View more
Author(s):
Alejandro de la Sierra
Added:
3 years ago
The Concepts of Metabolic Syndrome and Cardiometabolic Risk
Cardiometabolic risk represents a situation where the possibilities of developing atherosclerotic cardiovascular disease and diabetes are significantly enhanced as a consequence of the presence of insulin resistance and atherogenic dyslipidaemia. Dyslipidaemia is characterised by the presence of low high-density lipoprotein (HDL)…
View more
The TALENT Study
Author(s):
Giuseppe Mancia
Added:
3 years ago
Article
Author(s):
Robert H Fagard
Added:
3 years ago
After the initial investigations by Perloff et al.,1 our knowledge of the prognostic significance of ambulatory blood pressure (ABP) measurements has considerably increased. There is currently little doubt that 24-hour ABP is a better predictor of mortality and morbidity than conventional or office blood pressure (BP). This has been shown in the general population, in elderly, in treated and…
View more
Author(s):
Isabella Sudano
,
Eva Gerdts
,
Juan Tamargo
Added:
1 year ago
In the first of a three-part ECR Podcast series on hypertension in women, Dr Isabella Sudano (University Hospital and University of Zurich, Zurich, CH) and Dr Eva Gerdts (Haukeland University Hospital, Bergen, NO) are joined by Prof Juan Tamargo (University Complutense, Madrid, ES) to discuss pharmalogical treatment options and considerations.
Discussion points for this episode include:
Are…
View more
Author(s):
Alejandro de la Sierra
Added:
3 years ago
Despite the presence of an artificial debate developed in the past decade1,2 focusing on calcium channel blockers and their role in the prevention and treatment of cardiovascular diseases, a huge amount of evidence has been created favouring this class of agents in the treatment of hypertension and associated cardiovascular diseases.3 Calcium channel blockers are divided into three classes, the…
View more
Author(s):
Claudio Borghi
,
Arrigo FG Cicero
Added:
3 years ago
It is well known that hypertension is a strong independent risk factor for coronary and cerebrovascular diseases, as well as for heart failure, atrial fibrillation and chronic renal failure, in both industrialised and developing countries,1 thus substantially contributing to the global burden of disease. Moreover, it is well known that reducing blood pressure (BP) in hypertensive patients is…
View more
Author(s):
Cristina Sierra
,
Antonio Coca
Added:
3 years ago
Hypertension Treatment
The aim of antihypertensive treatment is to reduce the cardiovascular morbidity and mortality associated with high blood pressure (BP) levels by measures aimed at reducing BP levels and minimising the impact of possible associated risk factors or co-morbidities.1–5 This therapeutic goal requires previous cardiovascular risk stratification to assess the global risk of…
View more
Author(s):
Peter M Nilsson
Added:
3 years ago
Some cardiovascular (CV) risk-prone patients are easy to recognise, for example following manifestations of cardiovascular disease (CVD), coronary artery bypass graft (CABG) or percutaneous transluminal coronary angioplasty (PTCA) interventions, and they deserve appropriate risk-factor control for secondary prevention, including blood pressure (BP) lowering. However, many other at-risk patients…
View more